A receptor–ligand interaction exclusive to natural killer (NK) cell–mediated recognition and triggering of tumor cell destruction has not yet been identified. In contrast, molecules that are involved in cellular adhesion and regulation of NK cytolysis have been well studied. In this report, a novel tumor surface protein is identified that exhibits characteristics of a recognition structure for naive NK cells. A tagged ligand–cell adsorption technique revealed a 38.5-kD plasma membrane protein (p38.5) from a prototypical NK-susceptible cell line (K562) that preferentially bound to NK cells (CD3−CD5−CD16+) relative to T lymphocytes (CD3+CD5+ CD16−). The molecule was purified to apparent homogeneity for further characterization. An amino acid sequence of an 11-mer internal peptide of p38.5 did not exhibit homology to known proteins. Affinity-purified antibody generated against this peptide (anti-p38.5) reacted with a single protein of 38.5 kD on Western blots of whole cell extracts of K562. Flow cytometry and immunoprecipitation studies of surface-labeled tumor cells demonstrated expression of p38.5 on NK-susceptible tumor cell lines (K562, MOLT-4, Jurkat), whereas p38.5 was not detected on NK-resistant tumor cell lines (A549, Raji, MDA-MB-231). Significantly, p38.5 loss variants derived from wild-type Jurkat and Molt-4 cell lines exhibited decreased susceptibility to NK cell–mediated lysis demonstrating a strong association between cell surface expression of p38.5 and cytotoxicity. Purified p38.5 retained preferential binding to NK cells and inhibited NK activity in a dose-dependent manner, thereby providing direct evidence of a role in the lytic process. Binding studies identified a 70-kD membrane protein from NK cells as a possible receptor for the p38.5 tumor ligand. Consistent with cellular adsorption studies, the 70-kD, p38.5 binding protein was not detected on T lymphocytes. Based on studies demonstrating selective binding of p38.5 to NK cells, lack of expression on NK-resistant tumor cell lines and ability of the purified molecule to block cytolysis, we conclude that p38.5 may serve as a recognition/triggering ligand for naive human NK cells.
Skip Nav Destination
Article navigation
19 May 1997
Article|
May 19 1997
Preferential Interaction of a Novel Tumor Surface Protein (p38.5) with Naive Natural Killer Cells
Ballabh Das,
Ballabh Das
From the Departments of Medicine, Surgery, Anatomy, and Cell Biology and the Transplantation Immunology and Immunogenetics Laboratories, State University of New York Health Science Center at Brooklyn, Brooklyn, New York 11203
Search for other works by this author on:
Mary O. Mondragon,
Mary O. Mondragon
From the Departments of Medicine, Surgery, Anatomy, and Cell Biology and the Transplantation Immunology and Immunogenetics Laboratories, State University of New York Health Science Center at Brooklyn, Brooklyn, New York 11203
Search for other works by this author on:
Shi-Zhen Tao,
Shi-Zhen Tao
From the Departments of Medicine, Surgery, Anatomy, and Cell Biology and the Transplantation Immunology and Immunogenetics Laboratories, State University of New York Health Science Center at Brooklyn, Brooklyn, New York 11203
Search for other works by this author on:
Allen J. Norin
Allen J. Norin
From the Departments of Medicine, Surgery, Anatomy, and Cell Biology and the Transplantation Immunology and Immunogenetics Laboratories, State University of New York Health Science Center at Brooklyn, Brooklyn, New York 11203
Search for other works by this author on:
Ballabh Das
From the Departments of Medicine, Surgery, Anatomy, and Cell Biology and the Transplantation Immunology and Immunogenetics Laboratories, State University of New York Health Science Center at Brooklyn, Brooklyn, New York 11203
Mary O. Mondragon
From the Departments of Medicine, Surgery, Anatomy, and Cell Biology and the Transplantation Immunology and Immunogenetics Laboratories, State University of New York Health Science Center at Brooklyn, Brooklyn, New York 11203
Shi-Zhen Tao
From the Departments of Medicine, Surgery, Anatomy, and Cell Biology and the Transplantation Immunology and Immunogenetics Laboratories, State University of New York Health Science Center at Brooklyn, Brooklyn, New York 11203
Allen J. Norin
From the Departments of Medicine, Surgery, Anatomy, and Cell Biology and the Transplantation Immunology and Immunogenetics Laboratories, State University of New York Health Science Center at Brooklyn, Brooklyn, New York 11203
Address correspondence to Allen J. Norin, SUNY Health Science Center at Brooklyn, 450 Clarkson Avenue, Box 1197, Brooklyn, NY 11203.
This work was supported, in part, by a research grant from the US Public Health Service (CA-47548).
1Abbreviations used in this paper: FBS, fetal bovine serum; HPBL, human peripheral blood lymphocytes; Hsp, heat shock protein.
Received:
October 31 1996
Revision Received:
February 06 1997
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1997
J Exp Med (1997) 185 (10): 1735–1742.
Article history
Received:
October 31 1996
Revision Received:
February 06 1997
Citation
Ballabh Das, Mary O. Mondragon, Shi-Zhen Tao, Allen J. Norin; Preferential Interaction of a Novel Tumor Surface Protein (p38.5) with Naive Natural Killer Cells. J Exp Med 19 May 1997; 185 (10): 1735–1742. doi: https://doi.org/10.1084/jem.185.10.1735
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement